James Peyer is the founder of Cambrian Biopharma. Cambrian Biopharma has raised $100M in total funding. Latest round: Series C. Backed by Korify Capital.
James Peyer is the Co-founder and CEO of Cambrian Biopharma, a biotech company focused on advancing healthspan-boosting therapeutics. He was recognized as the 2022 "BioTech Company CEO of the Year" by Biotech Breakthrough. Under his leadership, Cambrian Biopharma successfully closed a $100 million Series C funding round.
Full founder directory · Investor directory · Company funding database · Fundraising library